Projects
2021
—
Ongoing
Rapid Vaccine Manufacturing Diagnostic Study
MMGH is assisting the Inter-American Development Bank to prepare a rapid vaccine supply diagnostic study in support of work aimed at generating capacities in the countries that integrate PROSUR to produce ...
Client:
Inter-American Development Bank
2020
—
Ongoing
Development of European Region Immunization Agenda 2030
MMGH is supporting the WHO European Regional Office (EURO) in developing the Regional Immunization Agenda for the period 2021-2030 in alignment with the Global Immunization Agenda 2030 (IA2030). The Regional ...
Client:
World Health Organization (WHO)
2021
—
Ongoing
Seasonal influenza vaccine value proposition: Development of a generic use case analytical framework and validation of use cases and country archetypes
MMGH is supporting the US CDC and WHO to validate preliminary use cases and country archetypes previously developed for seasonal influenza vaccines. MMGH is conducting staekholder surveys, interviews and ...
Client:
US Centers for Disease Control and Prevention (US CDC)
2020
—
Ongoing
Development of the European Immunization Agenda 2030 (EIA2030) Operational Framework
MMGH is supporting the WHO European Regional Office (EURO) in developing its operational framework for its European Immunization Strategy 2030 (EIA2030 Strategy). The operational framework will focus on ...
Client:
World Health Organization (WHO)
2021
—
Ongoing
Strengthen Philippines Vaccine Manufacturing
In collobaration with a team of experts, MMGH is assisting The Asian Development Bank (ADB) to support the Department of Health and the Research Institute for Tropical Medicine (RITM) from Philippines ...
Client:
Asian Development Bank
2021
—
2021
Regional manufacturing of COVID-19 vaccines
MMGH is assisting the Asian Development Bank's Interdepartmental Vaccine Manufacturing Task Force to assess demand for COVID-19 vaccines and vaccine manufacturing capacity in developing countries in Asia ...
Client:
Asian Development Bank